Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Investigate the efficacy and safety of HSK16149 capsule in Chinese patients with Diabetic Peripheral Neuropathic Pain (DPNP) who had an inadequate response to Pregabalin, following 4 weeks treatment in comparison to Pregabalin
Epistemonikos ID: adb6bcaee73e7f9a9762a8f69660b3af9553cf88
First added on: Apr 17, 2026